Bradley Foster & Sargent’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-829
| Closed | -$272K | – | 476 |
|
|
2024
Q4 | $272K | Buy |
+829
| New | +$272K | ﹤0.01% | 424 |
|
|
2024
Q2 | – | Sell |
-554
| Closed | -$219K | – | 462 |
|
|
2024
Q1 | $219K | Buy |
+554
| New | +$219K | ﹤0.01% | 425 |
|
|
2023
Q4 | – | Sell |
-779
| Closed | -$298K | – | 447 |
|
|
2023
Q3 | $298K | Hold |
779
| – | – | 0.01% | 390 |
|
|
2023
Q2 | $298K | Sell |
779
-55
| -7% | -$21K | 0.01% | 390 |
|
|
2023
Q1 | $289K | Buy |
+834
| New | +$289K | 0.01% | 380 |
|
|
2022
Q4 | – | Sell |
-1,709
| Closed | -$421K | – | 442 |
|
|
2022
Q3 | $421K | Sell |
1,709
-6
| -0.3% | -$1.48K | 0.01% | 333 |
|
|
2022
Q2 | $519K | Buy |
1,715
+490
| +40% | +$148K | 0.01% | 322 |
|
|
2022
Q1 | $503K | Hold |
1,225
| – | – | 0.01% | 348 |
|
|
2021
Q4 | $575K | Sell |
1,225
-25
| -2% | -$11.7K | 0.01% | 310 |
|
|
2021
Q3 | $531K | Sell |
1,250
-25
| -2% | -$10.6K | 0.01% | 297 |
|
|
2021
Q2 | $458K | Hold |
1,275
| – | – | 0.01% | 319 |
|
|
2021
Q1 | $359K | Sell |
1,275
-75
| -6% | -$21.1K | 0.01% | 322 |
|
|
2020
Q4 | $382K | Sell |
1,350
-75
| -5% | -$21.2K | 0.01% | 317 |
|
|
2020
Q3 | $392K | Buy |
+1,425
| New | +$392K | 0.01% | 274 |
|
|
2020
Q1 | $217K | Sell |
1,425
-100
| -7% | -$15.2K | 0.01% | 308 |
|
|
2019
Q4 | $229K | Sell |
1,525
-100
| -6% | -$15K | 0.01% | 341 |
|
|
2019
Q3 | $230K | Hold |
1,625
| – | – | 0.01% | 323 |
|
|
2019
Q2 | $203K | Buy |
+1,625
| New | +$203K | 0.01% | 340 |
|
|
2018
Q4 | – | Sell |
-1,700
| Closed | -$210K | – | 369 |
|
|
2018
Q3 | $210K | Buy |
+1,700
| New | +$210K | 0.01% | 353 |
|
|
2017
Q4 | – | Sell |
-2,240
| Closed | -$216K | – | 362 |
|
|
2017
Q3 | $216K | Hold |
2,240
| – | – | 0.01% | 343 |
|
|
2017
Q2 | $212K | Buy |
+2,240
| New | +$212K | 0.01% | 334 |
|